Imcor nets patent

Ultrasound contrast developer Imcor Pharmaceutical of San Diego has received a U.S. patent for a method of forming stabilized microbubbles using perfluorocarbons and other gases in various membrane-forming materials.

The firm said it has more than 30 patents in the U.S. and in other countries that cover ultrasound contrast agents and harmonic imaging.

By staff writers
February 9, 2005

Copyright © 2005

Page 1 of 510
Next Page